Lee W, Lin S, Chiang C, Chen J, Chieng W, Huang S
Stem Cell Rev Rep. 2024; 20(8):2194-2214.
PMID: 39264501
PMC: 11554697.
DOI: 10.1007/s12015-024-10774-8.
Arribas L, Menendez-Arias L, Betancor G
Int J Mol Sci. 2024; 25(13).
PMID: 39000271
PMC: 11241228.
DOI: 10.3390/ijms25137167.
Sun H, Luo M, Zhou M, Zheng L, Li H, Esworthy R
J Mol Cell Biol. 2024; 16(5).
PMID: 38714348
PMC: 11574390.
DOI: 10.1093/jmcb/mjae019.
Tettey-Matey A, Di Pietro C, Donati V, Mammano F, Marazziti D
Methods Mol Biol. 2024; 2801:147-176.
PMID: 38578420
DOI: 10.1007/978-1-0716-3842-2_12.
Nemirov K, Authie P, Souque P, Moncoq F, Noirat A, Blanc C
Front Immunol. 2023; 14:1208041.
PMID: 37654495
PMC: 10466046.
DOI: 10.3389/fimmu.2023.1208041.
IFITM1 inhibits trophoblast invasion and is induced in placentas associated with IFN-mediated pregnancy diseases.
Degrelle S, Buchrieser J, Dupressoir A, Porrot F, Loeuillet L, Schwartz O
iScience. 2023; 26(7):107147.
PMID: 37434700
PMC: 10331461.
DOI: 10.1016/j.isci.2023.107147.
HIV Reservoir: How to Measure It?.
Zhang X, Chen J
Curr HIV/AIDS Rep. 2023; 20(2):29-41.
PMID: 37004676
DOI: 10.1007/s11904-023-00653-1.
Assessing the Impact of Persistent HIV Infection on Innate Lymphoid Cells Using In Vitro Models.
Boulay A, Trabanelli S, Boireau S, Boyer-Clavel M, Nisole S, Romero P
Immunohorizons. 2023; 7(3):243-255.
PMID: 37000496
PMC: 10563434.
DOI: 10.4049/immunohorizons.2300007.
Lentiviral Vectors as a Vaccine Platform against Infectious Diseases.
Nemirov K, Bourgine M, Anna F, Wei Y, Charneau P, Majlessi L
Pharmaceutics. 2023; 15(3).
PMID: 36986707
PMC: 10053212.
DOI: 10.3390/pharmaceutics15030846.
Sec61 blockade therapy overrides resistance to proteasome inhibitors and immunomodulatory drugs in multiple myeloma.
Domenger A, Ricci D, Mayau V, Majlessi L, Marcireau C, Dadaglio G
Front Oncol. 2023; 13:1110916.
PMID: 36776330
PMC: 9911829.
DOI: 10.3389/fonc.2023.1110916.
Therapeutic modulation of gene expression in the disease state: Treatment strategies and approaches for the development of next-generation of the epigenetic drugs.
Rittiner J, Cumaran M, Malhotra S, Kantor B
Front Bioeng Biotechnol. 2022; 10:1035543.
PMID: 36324900
PMC: 9620476.
DOI: 10.3389/fbioe.2022.1035543.
Delivering genes with human immunodeficiency virus-derived vehicles: still state-of-the-art after 25 years.
Wolff J, Mikkelsen J
J Biomed Sci. 2022; 29(1):79.
PMID: 36209077
PMC: 9548131.
DOI: 10.1186/s12929-022-00865-4.
A lentiviral vector expressing a dendritic cell-targeting multimer induces mucosal anti-mycobacterial CD4 T-cell immunity.
Anna F, Lopez J, Moncoq F, Blanc C, Authie P, Noirat A
Mucosal Immunol. 2022; 15(6):1389-1404.
PMID: 36104497
PMC: 9473479.
DOI: 10.1038/s41385-022-00566-z.
Lentiviral Vectors for Ocular Gene Therapy.
Arsenijevic Y, Berger A, Udry F, Kostic C
Pharmaceutics. 2022; 14(8).
PMID: 36015231
PMC: 9414879.
DOI: 10.3390/pharmaceutics14081605.
Integrase deficient lentiviral vector: prospects for safe clinical applications.
Yew C, Gurumoorthy N, Nordin F, Tye G, Wan Kamarul Zaman W, Tan J
PeerJ. 2022; 10:e13704.
PMID: 35979475
PMC: 9377332.
DOI: 10.7717/peerj.13704.
Gene-Based Natural Killer Cell Therapies for the Treatment of Pediatric Hematologic Malignancies.
Rahnama R, Christodoulou I, Bonifant C
Hematol Oncol Clin North Am. 2022; 36(4):745-768.
PMID: 35773048
PMC: 10158845.
DOI: 10.1016/j.hoc.2022.03.007.
A Humanized Mouse Strain That Develops Spontaneously Immune-Mediated Diabetes.
Luce S, Guinoiseau S, Gadault A, Letourneur F, Nitschke P, Bras M
Front Immunol. 2021; 12:748679.
PMID: 34721418
PMC: 8551915.
DOI: 10.3389/fimmu.2021.748679.
Brain cross-protection against SARS-CoV-2 variants by a lentiviral vaccine in new transgenic mice.
Ku M, Authie P, Bourgine M, Anna F, Noirat A, Moncoq F
EMBO Mol Med. 2021; 13(12):e14459.
PMID: 34647691
PMC: 8646827.
DOI: 10.15252/emmm.202114459.
Lentiviral Vectors for Delivery of Gene-Editing Systems Based on CRISPR/Cas: Current State and Perspectives.
Dong W, Kantor B
Viruses. 2021; 13(7).
PMID: 34372494
PMC: 8310029.
DOI: 10.3390/v13071288.
The Host Protein Aquaporin-9 is Required for Efficient Sporozoite Entry into Human Hepatocytes.
Amanzougaghene N, Tajeri S, Yalaoui S, Lorthiois A, Soulard V, Gego A
Front Cell Infect Microbiol. 2021; 11:704662.
PMID: 34268141
PMC: 8276244.
DOI: 10.3389/fcimb.2021.704662.